Publicaciones (53) Publicaciones de IVAN FERNANDEZ BUENO

2024

  1. Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes

    Stem Cell Research and Therapy, Vol. 15, Núm. 1

  2. Evaluation of the neuroprotective efficacy of the gramine derivative ITH12657 against NMDA-induced excitotoxicity in the rat retina

    Frontiers in Neuroanatomy, Vol. 18

2023

  1. Ala®sil chemical characterization and toxicity evaluation: an example of the need for the Medical Device Regulation 2017/745

    Frontiers in Pharmacology, Vol. 14

  2. Does PLEX® Elite 9000 OCT Identify and Characterize Most Posterior Pole Lesions in Highly Myopic Patients?

    Journal of Clinical Medicine, Vol. 12, Núm. 5

  3. Safety, biocompatibility, and potential functionality of a new accommodative intraocular lens: An experimental study in rabbits

    Heliyon, Vol. 9, Núm. 9

2022

  1. Design, development, and implementation of non-face-to-face dynamization strategies in a Master’s in science subject

    EDULEARN22 Proceedings: 14th International Conference on Education and New Learning Technologies (July 4th-6th, 2022, Palma, Spain)

  2. Factors influencing mesenchymal stromal cells in in vitro cellular models to study retinal pigment epithelial cell rescue

    Human Cell, Vol. 35, Núm. 4, pp. 1005-1015

  3. Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration

    Frontiers in Neuroanatomy, Vol. 16

  4. Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death

    Investigative ophthalmology & visual science, Vol. 63, Núm. 4, pp. 27

2021

  1. Caracterización de la autofagia en un modelo in-vitro deneurodegeneración retiniana

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 43

  2. Dexamethasone PLGA Microspheres for Sub-Tenon Administration: Influence of Sterilization and Tolerance Studies

    Pharmaceutics, Vol. 13, Núm. 2, pp. 228

  3. Dexamethasone plga microspheres for sub-tenon administration: Influence of sterilization and tolerance studies

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-21

  4. Evaluación de la necroptosis en un modelo organotípico e neurodegeneración retiniana

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 86

  5. Ex Vivo Model of Spontaneous Neuroretinal Degeneration for Evaluating Stem Cells’ Paracrine Properties

    Methods in Molecular Biology (Humana Press Inc.), pp. 125-137

  6. Ex-Vivo Method to Quantifiably Evaluate the Staining Effectiveness of Anterior Lens Capsule Dyes

    Translational vision science & technology, Vol. 10, Núm. 14, pp. 17

  7. Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid

    Scientific Reports, Vol. 11, Núm. 1

  8. Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome

    Neural Regeneration Research, Vol. 16, Núm. 1, pp. 117-118

  9. Participants satisfaction and students academic results from transforming a face-to-face master in science subject into remote teaching and assessment

    EDULEARN21 Proceedings: 13th International Conference on Education and New Learning Technologies (July 5th-6th, 2021, Online)

2020

  1. Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery

    Regulatory Toxicology and Pharmacology, Vol. 110

  2. Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration

    Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 1155-1166